SIP
AGN

Stoneridge Investment Partners’s Allergan Inc AGN Stock Holding History

Stoneridge Investment Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-11,731
Closed -$988K – 262
2013
Q2 		$988K Buy
+11,731
New +$1.22M 0.23% 88

Other funds holding AGN

LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Stoneridge Investment Partners's AGN Position: Q3 2013 in Review

Stoneridge Investment Partners sold out of Allergan Inc (AGN) in Q3 2013, closing a stake of 11,731 shares — an estimated $988K sold.

Stoneridge Investment Partners first reported a position in AGN in Q2 2013 and held it in 1 quarter. The position peaked at $988K in Q2 2013. 642 funds tracked by Wall St. Rank hold AGN as of Q3 2013.

  • Stoneridge Investment Partners reported no remaining Allergan Inc position as of Q3 2013 after selling out during the quarter.
  • Stoneridge Investment Partners sold 11,731 Allergan Inc shares in Q3 2013, an estimated $988K.
  • Stoneridge Investment Partners first reported a position in Allergan Inc in Q2 2013 and held it in 1 quarter.
  • Stoneridge Investment Partners's Allergan Inc position peaked at $988K in Q2 2013.
  • 642 funds tracked by Wall St. Rank held Allergan Inc as of Q3 2013.

Based on Stoneridge Investment Partners's 13F filing for Q3 2013, filed 15 Oct 2013.